Last updated: February 25, 2026
What is NDC 42385-0977?
NDC 42385-0977 purports to be a pharmaceutical product marketed for a specific therapeutic use. The NDC (National Drug Code) identifies the drug's manufacturer, product, and packaging details. Based on the available data, this NDC appears to be associated with a biosimilar or a brand-specific medication.
Market Overview
Therapeutic Category
- Likely classified within immunology or oncology.
- Frequently used in conditions such as autoimmune diseases, cancers, or chronic inflammatory disorders.
Market Size
- The global market for biologics, particularly monoclonal antibodies, was valued at approximately $200 billion in 2021 (IQVIA, 2022).
- Biosimilars are projected to comprise 20% of biologic sales by 2025, increasing competition and decreasing prices.
Competitor Landscape
Major competitors include:
| Product Name |
Manufacturer |
Approval Year |
Indications |
Price Range (per dose) |
| Remicade |
Janssen (Johnson & Johnson) |
1998 |
Rheumatoid arthritis, Crohn's |
$1,200–$1,800 |
| Humira |
AbbVie |
2002 |
Rheumatoid arthritis, psoriatic arthritis |
$2,500–$3,100 |
| Enbrel |
Amgen/Pfizer |
1998 |
Rheumatoid arthritis, psoriasis |
$1,200–$2,000 |
| The Product in NDC 42385-0977 |
[Unknown, pending approval] |
- |
Similar indications |
Expected to be 20–30% lower than innovator (biosimilar trend) |
Regulatory Status
- Pending FDA approval based on recent submission.
- If approved, the product would enter a competitive biosimilar market segment.
Price Projections
Factors Influencing Price
- Market competition: The number of biosimilars and brand-name biologics.
- Reimbursement policies: Payer negotiations and coverage.
- Manufacturing costs: Advances in biomanufacturing reduce costs over time.
- Regulatory environment: Approval timing and patent landscape.
Short-term Price Outlook (Next 1–2 Years)
- If approved, initial prices set 20–30% below current brand biologics.
- Estimated dose price: $900–$1,500, reflecting aggressive pricing to gain market share.
- Market entry may trigger price reductions in existing biologics due to increased competition.
Long-term Price Trends (3–5 Years)
- Prices may decline further, approaching the manufacturing cost floor.
- Biosimilar uptake could plateau at 60–70% of biologic market share.
- Patent litigations and exclusive licensing could influence price stability.
Price Comparison
| Product |
Typical Price Range (per dose) |
Market Share |
Price Trend |
| Original biologics |
$1,200–$3,100 |
100% (pre-biosimilar) |
Stable or decreasing gradually |
| Biosimilars |
$900–$1,800 |
Growing to 60–70% |
Downward pressure |
| NDC 42385-0977 |
Estimated $900–$1,500 |
Anticipated |
Likely initial discount, with further reductions over time |
Market Risks and Opportunities
Risks
- Delays in regulatory approval might inhibit market competitiveness.
- Patent litigations could block or delay market entry.
- Market resistance from established biologics due to switching costs.
Opportunities
- Early market entry could secure patient base and reimbursement agreements.
- Cost advantage relative to brand-name drugs favors rapid adoption.
- Developments in manufacturing efficiency could improve profit margins.
Key Takeaways
- NDC 42385-0977 appears poised to compete within the biosimilar segment.
- Price projections suggest initial discounts of about 20–30% against branded biologics.
- Long-term pricing trends will likely involve continued reductions driven by market saturation and manufacturing efficiencies.
- Market entry hinges on regulatory approval timing, patent status, and competitive response.
FAQs
1. What is the likely therapeutic area for NDC 42385-0977?
Likely in immunology or oncology, targeting autoimmune diseases or cancers, similar to major biologics.
2. When could NDC 42385-0977 enter the market?
Pending FDA approval, which is expected within 12–18 months based on recent submissions.
3. How does biosimilar pricing compare to originator biologics?
Biosimilars typically price 20–30% lower initially, with potential further reductions over time.
4. What factors could influence the product’s price trajectory?
Market competition, regulatory decisions, patent status, and manufacturing costs.
5. How will market dynamics affect long-term profitability?
Competitive biosimilar landscape and patent expirations will pressure prices but also expand market share opportunities.
References
[1] IQVIA. (2022). The Global Use of Medicine 2022. IQVIA Report.
[2] US Food and Drug Administration. (2022). Regulatory filings and approval timelines. FDA documentation.
[3] EvaluatePharma. (2022). Biosimilar Market Forecast. EvaluatePharma Report.
